Titre:
  • Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.
Auteur:Rothenberg, Marc E; Roufosse, Florence; Faguer, Stanislas; Gleich, Gerald J; Steinfeld, Jonathan; Yancey, Steven W; Mavropoulou, Eleni; Kwon, Namhee; HES Mepolizumab Study Group,
Informations sur la publication:The journal of allergy and clinical immunology. In practice, 10, 9, page (2367-2374.e3)
Statut de publication:Publié, 2022-09
Sujet CREF:Médecine pathologie humaine
Mots-clés:Baseline blood eosinophil count
Fatigue
Flare
Hypereosinophilic syndrome
IL-5
Mepolizumab
MeSH keywords:Antibodies, Monoclonal, Humanized -- therapeutic use
Child
Eosinophils
Humans
Hypereosinophilic Syndrome -- drug therapy
Interleukin-5
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:E233881
info:doi/10.1016/j.jaip.2022.04.037
info:pii/S2213-2198(22)00482-2
info:scp/85134590880
info:pmid/35568330